Search

for
Search:

GlossaryThiazolidinediones (glitazones)

medications that increase insulin sensitivity to treat type 2 diabetes

Thiazolidinediones, also known as TZDs or glitazones, are a class of medications primarily used to treat type 2 diabetes. They work by increasing the body's sensitivity to insulin, thereby helping to control blood sugar levels. These drugs activate a specific receptor called PPAR-gamma, which influences the regulation of glucose and lipid metabolism.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 61 results

research Cardiovascular Profile of Pharmacological Agents Used for the Management of Polycystic Ovary Syndrome

4 citations , January 2019 in “Therapeutic Advances in Endocrinology and Metabolism”

Medications for PCOS don't seem to raise heart disease risk.

research Clinical Aspects of the Metabolic Syndrome

December 2017

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

research Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome

January 2017 in “Open Journal of Endocrine and Metabolic Diseases”

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

research Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review

April 2024 in “Curēus”

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

research Impact of Metformin and Rosiglitazone Treatment on Glucose Transporter 4 mRNA Expression in Women with Polycystic Ovary Syndrome

40 citations , April 2008 in “European journal of endocrinology”

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

View more "glitazones" in research →

Community Join

0 / 0 results

— no results